Has your child been affected by neuroblastoma? Call 020 7284 0800 for help and information.

Latest on Research

Pioneering children’s cancer research role to speed up crucial clinical trials

We’re delighted to let you know about our funding of a ground-breaking role to enable more children with neuroblastoma to access potentially life-saving clinical trials more quickly. In the first dedicated position focusing on a single childhood cancer, Dr Emmanouela Gbandi was appointed as the Solving Kids’ Cancer Senior Trials Coordinator for Neuroblastoma at the

Read story

Solving Kids’ Cancer announces ambitious research plans

Since the establishment of our Scientific Advisory Board in September, we’ve been working hard to develop the Solving Kids’ Cancer Research Strategy and associated operational elements. This will be used to shape the decisions we make and direction we take with our research funding. Right at the very heart of this remains the well-being of

Read story

SKC Appoint Scientific Advisory Board of International Repute

We are delighted to announce that we have appointed a Scientific Advisory Board (SAB) of international repute, concentrating specifically on developing a Research Strategy for Solving Kids’ Cancer and to oversee the development of a formal, structured and accredited research funding award process. Professor Andy Pearson, Dr John Maris, Dr Juliet Gray and Dr Lucas

Read story

Harvey Hext’s legacy funds groundbreaking trial for children with neuroblastoma

Around £100,000 raised to help Harvey Hext – a little boy who captured the hearts of the Chew Valley and the wider world before passing away from cancer – is being used to part fund a pioneering new drug trial that will benefit children diagnosed with neuroblastoma in the UK. Harvey was 3 years old

Read story

Oscar Knox’s parents hail donors for making new drug trial reality

The parents of Oscar Knox – the little boy from Mallusk who captured hearts around the world before passing away from cancer – have thanked donors for the £60,000 that will help fund trials of what could be a pioneering new drug. Wee Oscar, as he became known, was diagnosed with neuroblastoma in 2011. His

Read story

A perfect storm

Globally, one child per million is diagnosed with high-risk neuroblastoma every year. Solving Kids’ Cancer is working to ensure that child can beat the odds The most common extracranial solid tumour in childhood, and arguably one of the least well-known, neuroblastoma is a cancer of the sympathetic nervous system which occurs in infants more often than

Read story

New genetic testing for children with neuroblastoma

Scientists at the Institute of Cancer Research and Royal Marsden Hospital have developed a new genetic test that will be given to children with solid tumours in an effort to analyse genetic changes in 81 cancer genes, with funding from Christopher Smile. This is the first stage of an initiative to bring these tests to

Read story


A new drug may overcome treatment resistance in neuroblastoma. Researchers at the Children’s Hospital of Philadelphia have identified a promising new drug against forms of neuroblastoma that have an ALK mutation. The ALK gene is mutated in around 10-15% of neuroblastoma tumours at diagnosis and significantly increased at relapse. This new drug (PF-06463922) has shown

Read story

NICE Consultation

As you may already be aware the NICE (National Institute for Health and Care Excellence) recently published interim guidance that dinutuximab (Unituxin, ch14.18/SP2/0) in combination with GM-CSF and IL-2 is not recommended for use on the NHS in England and Wales as it does not represent a cost-effective use of resources.  Nick Bird (dad to

Read story

A way to target the Achilles heel of neuroblastoma

Some interesting research coming out of Australia at present. Read more here.    

Read story

Join our newsletter

Privacy Policy (click to expand)

Follow Us

Useful links

Contact us

Solving Kids' Cancer

Tel: 020 7284 0800

CAN Mezzanine
49-51 East Road
N1 6AH

Contact us